MS Speaks

Multiple Sclerosis => TREATMENTS => LEMTRADA (Campath, alemtuzumab) => Topic started by: agate on January 29, 2018, 06:40:19 pm

Title: (Absts.) Two adverse events with Lemtrada reported
Post by: agate on January 29, 2018, 06:40:19 pm

From Multiple Sclerosis Journal, January 23, 2018--


"Life-threatening autoimmune warm hemolytic anemia following treatment for multiple sclerosis with alemtuzumab":


http://journals.sagepub.com/doi/abs/10.1177/1352458517729766


And in the same issue--"Simultaneous early-onset autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis":


http://journals.sagepub.com/doi/abs/10.1177/1352458517743093